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OUT WITH THE OLD, IN WITH THE NEW?
Improving Clinical Outcome in Patients with Hypertrophic Obstructive
Cardiomyopathy
Elise Shellenberger & Elizabeth Thompson

Abstract
Objective: Review two studies that assess alcohol septal ablation (ASA) and surgical
myectomy as treatment options for patients with drug refractory hypertrophic obstructive
cardiomyopathy (HOCM). Background: Controversy exists regarding these two forms
of treatment for HCOM. Design: Two observational cohort studies. Methods: A search
was done on PubMed, utilizing the terms “hypertrophic cardiomyopathy,” “alcohol septal
ablation,” and “myectomy.” The following limits were used: published in the last 15
years, humans, English, and comparative studies. Results: Study One4 showed that the
patients undergoing ASA had a lower periprocedural complication frequency compared
to those undergoing myectomy (14% [22 of 161] versus 28% [29 of 102], p-value 0.004).
Patients undergoing ASA also had a significantly shorter follow-up stay than those
undergoing myectomy (5 days versus 9 days, p-value <0.001). Multivariate analysis
showed that age was the only independent predictor of long-term mortality (hazard ratio
1.34, 95% CI 1.08-1.65, p-value 0.007). Study Two5 showed that the resting pressure
gradient (PG) was significantly decreased following both procedures (64 ± 39 mmHg to
24 ± 19 mmHg for ASA, and 62 ± 43 mmHg to 11 ± 6 mmHg for myectomy, both p <
0.0001) at 3-month follow up. The NYHA functional class was also significantly
improved in both groups; ASA patients from 3.5 ± 0.5 to 1.9 ± 0.7, and myectomy
patients from 3.3 ± 0.5 to 1.5 ± 0.7, both p-values < 0.0001). Conclusion: Both ASA and
surgical myectomy provide comparable clinical outcomes in patients. ASA is associated
with decreased hospital stay and less periprocedural complications. Surgical myectomy
provides more complete reduction in pressure gradient, but is a more invasive procedure.
ASA is a relatively new procedure therefore further studies will be helpful to validate it's
efficacy in comparison to myectomy.
Introduction
Hypertrophic cardiomyopathy (HCM) is the most common inherited myocardial
disorder and the most common cause of sudden death in young athletes. HCM affects 1
out of every 500 people and is more common in men than women.1 The genetic
mutations are passed in an autosomal dominant fashion and include defects in the cardiac
sarcomere proteins. These defects cause enlarged heart muscle cells and thick ventricular
walls resulting in abnormal diastolic function with impaired ventricular filling. The
characteristic left ventricular hypertrophy (LVH) results in a resting or exercise provoked
left ventricular outflow tract (LVOT) obstruction in 70% of patients. If the LVOT is
obstructed, the condition is characterized as hypertrophic obstructive cardiomyopathy

(HOCM)2. Any exercise that is strenuous enough to increase afterload will worsen the
hypertrophy and therefore worsen the obstruction and symptoms.
Dyspnea is the presenting symptom in 90% of HOCM patients. Other symptoms
include chest pain, palpitations, dizziness, syncope, and sudden death. Additionally,
patients can experience high blood pressure or arrhythmias due to disruption of the
heart’s electrical signals. For patients who are still symptomatic despite the use of first
line pharmacologic treatments such as beta blockers; surgical myectomy and alcohol
septal ablation (ASA) are two procedures that can reduce the LVOT obstruction and
improve New York Heart Association (NYHA) functional class.
Surgical myectomy has been performed for decades and involves direct removal
of the septal muscle. The removal of the hypertrophied muscle relieves the obstruction
and increases the amount of blood able to leave the left ventricle thereby improving
systolic function of the heart. Complications of the procedure include a ventricular septal
defect, a left bundle branch block, or complete heart block necessitating a permanent
pacemaker. Because myectomy requires a thoracotomy, patients often desire a less
invasive procedure. Alcohol septal ablation (ASA) is performed percutaneously as part of
a cardiac catheterization. During the procedure, ethanol is injected into a branch of a
septal perforator coronary artery to create a localized infarction and subsequent septal
remodeling over time, which results in a reduction in myocardial mass and therefore,
improved systolic function3. Complications of ASA include coronary artery dissection,
large myocardial infarction, complete heart block, and ventricular tachyarrhythmias. ASA
has also been associated with an increased risk of residual LVOT gradient due to noncomplete ablation, therefore requiring a repeat septal reduction procedure.

Clinical Question & Scenario
P. In patients with symptomatic hypertrophic obstructive cardiomyopathy
I. Does alcohol septal ablation
C. Compared to surgical myectomy
O. Decrease symptoms and improve long term outcome

A 55 year old male with diagnosed HOCM is severely symptomatic despite
pharmacologic treatments. Is septal myectomy or alcohol ablation the best
procedure for this patient?

Methods
An initial search of PubMed was performed in September 2015 using the terms
hypertrophic cardiomyopathy, alcohol septal ablation, and myectomy. Limits included
“published in the last 15 years,” “humans,” “comparative studies,” and “English”. This
yielded 13 articles. Ultimately, two promising studies were identified. Both studies were
single center non-randomized observational studies. Study 1 evaluated the periprocedural complications and long-term outcomes after ASA and myectomy, and study 2
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Results
Study # 1:
Periprocedural Complications and Long-Term Outcome After Alcohol Septal Ablation
Versus Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy. Steggerda et
al.4

Objective:
To compare surgical myectomy and alcohol septal ablation (ASA) for periprocedural
complications and long-term clinical outcome in patients with symptomatic hypertrophic
obstructive cardiomyopathy

Study design:
This was a nonrandomized, observational study of myectomy and ASA
procedures preformed in a Netherlands hospital between 1981 and 2010. Surgical
myectomy was carried out beginning in 1981 and ASA was carried out beginning in
2000. A retrospective analysis of baseline characteristics for patients who underwent
treatment is seen below in Table 1.
Patients who underwent myectomy were more likely to have angina and coronary
artery disease, while those who underwent ASA had increased septal and posterior wall
thickness.

Table 1: Baseline Patient Characteristics
Myectomy (n=102)

ASA (n= 161)

P value

Angina

2.3 ± 0.6

2.0 ± 0.5

0.002

Coronary a. disease

17%

5%

0.004

Septal thickness,

20(17-24)

21(19-24)

0.003

14 ± 3

15 ± 4

0.01

50 (25-75)

32 (18-75)

0.088

mm
Posterior wall
thickness, mm
Gradient baseline,
mmHg

To be eligible for either procedure, all patients were required to be severely
symptomatic despite medical therapy and all had a resting gradient of 30 mmHg or a
provocative gradient of at least 50 mmHg. Provocation testing using a Valsalva
maneuver, venodilators, or exercise stress testing is often required to induce the left
ventricular outflow tract obstruction associated with HOCM.
Myectomy was the required procedure for patients with hypertrophic
cardiomyopathy in addition to subvalular disease or coronary artery disease. Patients who
were eligible for myectomy or ASA were explained the risks and benefits and were able
to choose between the two procedures. 161 patients underwent ASA and 102 patients
required myectomy.
A transthoracic echocardiogram was performed in all patients before intervention
to measure the degree of left ventricular outflow tract (LVOT) obstruction. In patients
undergoing surgical myectomy, a transesophogeal echocardiogram was used
intraoperatively to measure the post-surgical LVOT gradient. In patients undergoing
ASA, the LVOT was measured invasively following the ablation procedure. Records
were obtained from all patients who had a follow up echocardiogram to determine the last
known ejection fraction and LVOT gradients after the procedures.
Periprocedural (30-day) complications were obtained through a retrospective
analysis of hospital records. Clinical outcome and long-term survival were investigated in
2010 using hospital records in addition to a mailed questionnaire with follow up
telephone inquiry when necessary. Questions focused on post procedural symptoms such
as chest pain and syncope, as well as the patients’ New York Heart Association
functional class status (1 to 4). Hospital records were obtained for clinical events that
required a re-admittance for heart failure or repeat cardiac intervention. For patients who
were not alive at the time of follow up, a cause of death was obtained from records.
All-cause mortality of both ASA and myectomy during a maximal follow-up
period of 11 years was the primary endpoint of the study. Annual cardiac death rates,
cerebral vascular accidents, myocardial infarctions, NYHA functional class, and heart
failure requiring re-hospitalization were all included as secondary endpoints.

Statistical analysis was performed using the Mann-Whitney U test and Student t
test to compare variables between the ASA and myectomy group. The Mann-Whitney
test was used to compare the two treatments and for analyzing the difference between the
medians of the data sets. The Student t test was then used to determine if the two sets of
date were significantly different. Because the sample groups in this study were
independent, this was an appropriate statistical analysis to use.
All cause mortality was determined using the Cox proportional hazard analysis.
This analysis is commonly used to estimate the risk of death for an individual after taking
into account different variables. In this particular study the baseline variables included
age, sex, NYHA functional class, medical history and echocardiogram findings. A pvalue of less than 0.05 was considered to be statistically significant.

Study results:
Periprocedural complications (30 days) were measured and included death, CVA,
ventricular tachycardia/fibrillation, tamponade, pacemaker implantation, and urgent
repeat thoracotomy. The ASA group had a lower periprocedural complication frequency
compared to the myectomy group (14% [22 of 161] versus 28% [29 of 102], p-value =
0.004). ASA group also had a significantly shorter follow-up stay than the myectomy
group (5 days versus 9 days, p-value = <0.001)
Maximal follow-up duration of 11 years showed that all-cause mortality was comparable
between ASA and myectomy groups (Figure 1). Univariate analysis was used to deal
with only one variable at a time without taking other variables into consideration. In this
study it demonstrated that age (per 5 years) and coronary artery disease were the only
statistically significant predictors of all-cause mortality. Age had a hazard ratio of 1.42
(95% CI 1.18-1.71, p-value <0.001) and coronary artery disease had a hazard ratio of
2.96 (95% CI 1.11-7.90, p-value 0.030). These hazard ratios were used to measure how
often death occurred in one group compared to how often it occurred in another group.
Multivariate analysis incorporated multiple prediction variables and it showed that age
was the only independent predictor of long-term mortality (hazard ratio 1.34, 95% CI
1.08-1.65, p-value 0.007)

(figure 1: Survival after ASA vs Myectomy)

96% of patients were still alive at follow-up and questionnaires regarding their
symptomatic status were administered. There were no differences in CVA, MI, rehospitalization for heart failure, or overall symptomatic status between the ASA and
myectomy groups. 92% of patients underwent a repeat echocardiogram during the late
follow-up period (3.9 ± 4.7 years) to measure the LVOT gradient. Patients who received
ASA had a higher gradient at late follow-up than the myectomy patients. This is
contrasted to the decreased gradient post procedure in the ASA group compared to the
myectomy group. There were a total of 10 reinterventions preformed after ASA due to a
significant residual gradient following the procedure but only 1 intervention was
necessary in the surgical myectomy group. Table 2 summarizes significant periprocedural
complications and clinical outcomes between the two procedure groups.

Table 2: Complications & Outcomes

Periprocedural

Myectomy (n=102)

ASA (n=161)

P value

28%

14%

0.004

9 (6-12)

5 (4-6)

<0.001

12( 8-20)

10 (0-20)

<0.001

9 (4-10)

10 (7-19)

0.003

1% (1)

6.3% (10)

0.055

complications
Length of hospital
stay, days
Post-procedural
gradient, mmHg
Late follow up
gradient, mmHg
Reintervention
within long term
follow up

Study #2:
Outcome of Patients with Hypertrophic Obstructive Cardiomyopathy After Percutaneous
Transluminal Septal Myocardial Ablation and Septal Myectomy Surgery. Qin et al.5

Objective:
To evaluate the subjective and objective follow-up results in patients undergoing alcohol
septal ablation and surgical myectomy for treatment of drug refractory hypertrophic
obstructive cardiomyopathy (HCOM).

Study design
This was a non-randomized cohort study of 51 symptomatic patients with
hypertrophic obstructive cardiomyopathy. The diagnosis of HOCM was based on the
presence of a hypertrophied, non-dilated left ventricle. All patients were symptomatic
and presented with angina (42%), dyspnea (78%), or syncope (24%), and a New York
Heart Association (NYHA) Functional class of at least III. Additionally, patients were
refractory to drug treatment and had a left ventricular outflow tract (LVOT) gradient ≥50
mmHg.

All 51 patients were informed of the two treatment methods, and gave informed
consent prior to the procedures. Twenty-six of the 51 patients underwent surgical
myectomy, and twenty-five underwent alcohol septal ablation. All patients had a
conventional two-dimensional ECHO and a doppler ECHO performed before the
procedure, immediately after the procedure, and at 3 month follow up. A transesophageal
echocardiogram TEE was only performed if suitable images could not be obtained prior
to the procedure. The interventricular septum thickness, the posterior wall thickness, and
the LV left ventricular ejection fraction were all assessed prior to undergoing a
procedure. Additionally, the peak pressure gradient through the LVOT was estimated
using the Bernoulli equation. This equation estimates the speed of a liquid based on the
inverse relationship between velocity and pressure as it moves from point A to point B.
Both procedures were deemed successful when the resting pressure gradient (PG)
was less than 16 mm Hg, or the percentage of pressure gradient reduction was more than
50%. The reduction was calculated using:
(PG before procedure- PG after procedure) x 100%
(PG before procedure)
After discharge following these procedures, all 51 patients underwent a clinical
evaluation by a cardiologist, which included assessment of NYHA functional class.
Follow up for myectomy was 128 ± 84 days, and follow up for ASA was 117 ± 36 days.

Study 2 Results
Patients who underwent alcohol septal ablation were significantly older (mean age
63 ± 14 years) and tended to have more comorbid conditions that could increase the risk
of surgery compared to those who underwent surgical myectomy (mean age 48 ± 13
years). Additionally, 58% of patients undergoing both procedures were on beta-blockers,
30% on calcium channel blockers, and 12% on both at the time of the procedure. There
was no difference in the intraventricular septal thickness between the two groups before
the procedures, but the interventricular sepum (IVS) thickness was significantly reduced
at follow up (2.3± 0.4 cm vs. 1.9 ± 0.4 for ASA compared to 2.4± 0.6 cm vs. 1.7 ± 0.2 cm
for myectomy).

In those patients undergoing ASA which was referred to as percutaneous
transluminal septal myocardial ablation (PTSMA) in this study, the resting pressure
gradient decreased from 64 ± 39 mmHg to 28 ± 29 mmHg after the procedure, and to 24
± 19 mmHg at 3 month follow up. Twenty-two of the 25 patients had a post procedure
PG of <16mmHg or a >50% reduction in PG at follow up, deeming the procedure
successful. In those undergoing myectomy, the resting pressure gradient decreased from
62 ± 43 mmHg to 7 ± 7 mmHg after the procedure, and to 11 ± 6 mmHg at 3 month
follow up. One hundred percent of the ASA patients had post procedure PG of <16mmHg
or a >50% reduction in PG at follow up, deeming the procedure successful. Between the
post procedure and the follow up period, four patients had resting PG increase slightly,
but it was still much lower than the PG before the procedure. At the 3-month follow-up
the PG was completely eliminated in 81% of patients receiving myectomy, while only
52% of of ASA patients showed a PG <16mmHg. These results are seen in Figure 3.

New York Functional Class was assessed both before and after treatment. This is a
standard classification used to assess the degree of heart failure. Class one patients have
cardiac disease but no symptoms, class two patients have mild symptoms, class three
patients have marked limitation in activity due to symptoms, and class four patients have
severe limitations.6 All 51 patients in this study had a NYHA functional class of ≥3.
ASA patients had an average class of 3.5 ± 0.5 that was decreased to 1.9 ± 0.7 after the
procedure. Myectomy patients had an average class of 3.3 ± 0.5 that was decreased to 1.5
± 0.7 after the procedure. Both of these values had a p value of < 0.001. These results are
seen in Figure 4.

There were no deaths reported within the 3 months following both treatments. After
undergoing ASA, 9 patients had complete right bundle branch block, and two patients
had complete left bundle branch block. Sixteen patients had left bundle branch block after
undergoing myectomy. The mean hospital stay for ASA patients was 5.6 ± 2.3 days
compared to 8.1 ± 3.5 days for the myectomy patients. Pacemakers were required in six
patients who underwent ASA and in 2 patients who underwent myectomy. These results
are seen in Table 3.
Table 3: Complications & Outcomes

In general, both alcohol septal ablation and surgical myectomy were found to improve
NYHA functional class, reduce the hypertrophied interventricular septum, and decrease
LVOT obstruction. Patients undergoing myectomy had a greater reduction in LVOT PG,
and those undergoing alcohol septal ablation had a shorter hospital stay.

Discussion
According to the two studies reviewed, clinical outcomes for HOCM patients are
comparable following both ASA and myectomy. Because ASA is a fairly new procedure
compared to myectomy, additional studies need to be done to arrive at a more definitive
conclusion.
Study 1 is the first to analyze both periprocedural (30 day) complications as well
as long-term (11 years) outcomes of the two treatments for HOCM. Previous studies
(such as Study 2, Qin et al.) did not address long-term results. Strengths of Study 1
included comparable clinical baseline characteristics in the ASA and myectomy groups
except for concomitant coronary artery disease and a slight difference in the degree of left
ventricular hypertrophy. Average age was also similar in both groups. Follow-up was
another strength of this study, as questionnaires were administered to 96% of the patients.
Telephone follow up was used to ensure accurate information when needed.
The fact that this was a non-randomized, observational study was a limitation
however a randomized control trial would be nearly impossible to conduct with HOCM
patients. The choice between an ablation and a myectomy is a personal one and patients
should have the right to choose the procedure that they feel is best for them and is most
appropriate procedure based on their individual condition. This study was conducted in
the Netherlands therefore may not be representative of the general HOCM population. A
potential source of bias was the fact that ASA procedures involved in this study began in
2000, whereas the myectomy procedures dated as far back as 1981. Additionally, bias
may have resulted because certain baseline characteristics were specific to each
treatment. Those with angina and coronary artery disease were more likely to undergo
myectomy while patients with posterior wall thickness were slightly increased in those
who underwent ASA. Furthermore, certain patients were required to have myectomy
while other patients were given the choice between the two procedures.

Study 1 concluded that long term symptomatic improvement and long-term
survival were comparable between the ASA and myectomy groups. ASA was shown to
be associated with less periprocedural complications than surgical myectomy, which had
not been reported in previous studies. The complications with myectomy, however, were
attributed to the more invasive nature of the procedure, and were not associated with a
worse long-term outcome. The surgical myectomy procedure also resulted in an increased
hospital stay compared to the less invasive alcohol septal ablation.
Strengths of Study 2 include systematic screening and follow up on all patients
with ECHO right after the procedure and at 3-month follow-up. The same parameters
were measured before and after the procedures were completed.
The two groups were dissimilar in many aspects. Older patients with significant
comorbid conditions underwent alcohol septal ablation, while younger patients had
myectomy. Follow-up was fairly short, and long-term results are unknown at this point.
Additionally, there was no criterion for dividing the patients into the two procedures,
treatment was chosen based on patient and physician preference. The sample size was
small therefore a student t test was used which compared the average of the study groups
to find significant differences.7 A p value of < 0.01 was considered statistically
significant, and a Chi squared test was used to compare success rates and complications
between the two study groups. All parameters measured in this study were statistically
significant (p value < 0.01) with the exception of the larger end diastolic diameter of the
LV in ASA group before the procedure (p= 0.03), and the end diastolic diameter of the
LV increasing after ASA (p= 0.01) and after myectomy (p= 0.06). Additionally, the
presence of bundle branch blocks after procedure (p> 0.05), and permanent pacemakers
required (p>0.05) were not statistically significant.
Study 2 concluded that both ASA and surgical myectomy reduce the
hypertrophied interventricular septum, decrease pressure gradient across the left ventricle
and improve NYHA functional class, thereby reducing symptoms. Those who underwent
ASA had a shorter hospital stay compared to those who underwent myectomy, but
patients who underwent myectomy had a greater reduction in PG,

Conclusion
In summary, long term survival and symptomatic improvement after both ASA and
myectomy is comparable. ASA is associated with decreased length of hospital stay
following the procedure as well as a decreased rate of periprocedural complications.
Because ASA is a less invasive procedure than surgical myectomy, it should be
considered when deciding on HOCM surgical treatment. As convenient and less invasive
as it is, it’s important to note that ASA will not be replacing surgical myectomy in the
treatment of symptomatic HOCM patients. Surgical myectomy may be the necessary
method if the patient has multivessel coronary artery disease or septal anatomy that is
unsuitable for alcohol ablation. For our clinical scenario, the 55-year-old patient should
meet with his cardiologist and surgeon to ensure that his personal preference is taken into
consideration in addition to his individual cardiovascular history.
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